SCAI/ACCF/HRS/ESC/SOLACI/APSIC statement on the use of live case demonstrations at cardiology meetings

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 4, 2010, Pages

  Dehmer, Gregory J ^a   Douglas Jr , John S ^a   Abizaid, Alexander ^a   Berg, Jessica W ^a   Day, John ^a   Hall, Roger ^a   Leon, Martin B ^a   Hijazi, Ziyad M ^a   Marchlinski, Francis ^a   Park, Seung Jung ^a   Popma, Jeffrey J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGY; CASE MANAGEMENT; CONFLICT OF INTEREST; CONGENITAL HEART DISEASE; HEART ELECTROPHYSIOLOGY; HUMAN; INFORMED CONSENT; INTERNET; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MEDICAL EDUCATION; MEDICAL ETHICS; MEDICAL SOCIETY; PARTICIPANT OBSERVATION; PATIENT EDUCATION; PATIENT PARTICIPATION; PATIENT RIGHT; PATIENT SAFETY; PATIENT SELECTION; PHYSICIAN; REVIEW; RISK ASSESSMENT; TELECOMMUNICATION; VIDEOTAPE;

CARDIOLOGY; CONFLICT OF INTEREST; CONGRESSES AS TOPIC; EDUCATION, MEDICAL; FORECASTING; HUMANS; INFORMED CONSENT; INTERNET; PATIENT RIGHTS; REMOTE CONSULTATION; RISK ASSESSMENT; TEACHING; TELECOMMUNICATIONS;

EID: 78649411167     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22719     Document Type: Review

References (29)

1. Liao Z, Li Z-S, Leung JW, et al.; China ERCP Live Demonstration and Education Study Group. How safe and successful are live demonstrations of therapeutic ERCP? A large multicenter study. Am J Gastroenterol 2009; 104: 47-52.
2. Packer ME, Rogers JO, Coward TJ, Newman PS, Wakeley R,. A comparison between videotaped and live demonstrations, for the teaching of removable partial denture procedures. Eur J Dent Educ 2001; 5: 17-22.
3. Harder J,. Society for Cardiovascular Angiography and Interventions. Personal communication. 2009.
4. Sade RM,; for the American Association for Thoracic Surgery Ethics Committee and the Society of Thoracic Surgeons Standards and Ethics Committee. Broadcast of surgical procedures as a teaching instrument in cardiothoracic surgery. Ann Thorac Surg 2008; 86: 357-361.
5. Dotter CT, Judkins MP,. Transluminal treatment of arteriosclerotic obstruction: Description of a new technique and a preliminary report of its application. Circulation 1964; 30: 654-670.
6. Gruentzig AR, Senning A, Siegenthaler WE,. Non-operative dilatation of coronary artery stenosis: Percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301: 61-68. (Pubitemid 9229695)
7. Chatelain P, Meier B, De La Serna, et al. Success with coronary angioplasty as seen at demonstrations of procedure. Lancet 1992; 340: 1202-1205.
8. Leon MB,. Transcatheter Cardiovascular Therapeutics (TCT) Case Archives. Personal communication. 2009.
9. Kirtane AJ, Gupta A, Iyengar S, et al. Safety and efficacy of drug-eluting and bare metal stents-Comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009; 119: 3198-3206.
10. Franke J, Reimers B, Scarpa M, et al. Complications of carotid stenting during live transmissions. J Am Coll Cardiol Interv 2009; 2: 887-891.
11. White CJ, Beckman JA, Cambria RP, et al. American Heart Association Writing Group 5. Atherosclerotic peripheral vascular disease symposium II: Controversies in carotid artery revascularization. Circulation 2008; 118: 2852-2859.
12. Accessed May 29, 2010.
13. Belluck P,. Webcast your brain surgery? Hospitals see marketing tool. The New York Times May 25, 2009.
14. Studdert DM, Mello MM, Brennan TA,. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry-Self-regulation in the shadow of federal prosecution. N Engl J Med 2004; 351: 1891-1900.
15. American Medical Association, Council on Ethical and Judicial Affairs. Accessed May 29, 2010.
16. Coyle SL,. Physician-industry relations, Part 1: Individual physicians. Ann Intern Med 2002; 136: 396-402.
17. ACCME Standards for Commercial Support. Standards to ensure the independence of CME activities. Accessed May 29, 2010.
18. Pharmaceutical Research and Manufactures of America. Code on Interactions with Healthcare Professionals. Accessed May 29, 2010.
19. Department of Health and Human Services, Office of the Inspector General. OIG compliance program for pharmaceutical manufacturers. Accessed May 29, 2010.
20. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest. A policy proposal for academic medical centers. JAMA 2006; 295: 429-433.
21. Industry Funding of Medical Education. Report of an AAMC Task Force. June 2008. Accessed May 29, 2010.
22. Rothman DJ, Chimonas S,. New developments in managing physician-industry relationships. JAMA 2008; 300: 1067-1069.
23. Relman AS,. Industry support of medical education. JAMA 2008; 300: 1071-1073.
24. Rothman DJ, McDonald WJ, Berkowitz CD, et al. Professional medical associations and their relationships with industry. JAMA 2009; 301: 1367-1372.
25. Heart Rhythm Society Code of Ethics and Professional Standards. Accessed January 16, 2010.
26. Popp R,. Conflict of interest for the physician-inventor using a device in human subjects. Am Heart J 2005; 149: 1-3.
27. Department of Health and Human Services. Accessed May 29, 2010.
28. Sutherell JS, Hirsch R, Beekman RH III,. Pediatric interventional cardiology in the United States is dependent on the off-label use of medical devices. Congenit Heart Dis 2010; 5: 2-7.
29. United States Food and Drug Administration. Accessed May 29, 2010.